BRCA1 and ovarian cancer: For example, methylation of the BRCA1 promoter has been shown to transcriptionally silence BRCA1 [16] leading to lower levels of BRCA1 messenger RNA (mRNA), which correlates with disease characteristics of breast and ovarian cancers [17].